Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
192
394
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Diagnos Laboratorium Utama PT Tbk
Common Shares Outstanding
Diagnos Laboratorium Utama PT Tbk
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
Common Shares Outstanding
Rp1.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Prodia Widyahusada Tbk PT
IDX:PRDA
|
Common Shares Outstanding
Rp937.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Diagnos Laboratorium Utama PT Tbk
Glance View
PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. The company employs 54 full-time employees The company went IPO on 2021-01-15. The firm is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouses, eye banks, sperm banks and blood banks, organ transplant banks, and other medical support services. The company operates through providing health services using laboratories segment. The Company’s products and services include clinical pathology laboratory, anatomy pathology laboratory, genomic laboratory, homecare health services, corporate health services, and Covid-19 checkup. The firm serves markets, such as Jakarta, Depok, Bali, Bandung, Bekasi, Padang, Makassar, Tangerang Selatan, Dumai, Batam, Purwakarta, Karawang, and Brebes. The company has branch offices in Ciputat (South Tangerang), Denpasar (Bali), Padang (West Sumatra), and Makassar, South Sulawesi.
See Also
What is Diagnos Laboratorium Utama PT Tbk's Common Shares Outstanding?
Common Shares Outstanding
1.3B
IDR
Based on the financial report for Dec 31, 2023, Diagnos Laboratorium Utama PT Tbk's Common Shares Outstanding amounts to 1.3B IDR.
What is Diagnos Laboratorium Utama PT Tbk's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
0%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Diagnos Laboratorium Utama PT Tbk have been 8% over the past three years .
You don't have any saved screeners yet
